BridgeMD
New treatment option for Overweight and Obese Women
Official title Impact of Beta-glucan Supplementation During Calorie and Carbohydrate-restricted Diet on Body Weight and Body Fat Loss, Appetite, and Gastrointestinal Appetite Hormones.
ClinicalTrials.gov ID: NCT07299942
What this study is testing
What is Beta-glucan addition to a restricted calorie of meal replacements and carbohydrate diet.?
Beta-glucan addition to a restricted calorie of meal replacements and carbohydrate diet. is an investigational medicine, given as an once-weekly, being studied as a potential treatment for overweight and obese women.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will investigate whether beta-glucan supplementation, when added to an energy and carbohydrate-restricted diet, facilitates body weight and body fat loss, and leads to less detrimental changes in subjective appetite and gastrointestinal appetite hormones. This will be a double-blind, randomised, controlled trial in which healthy females living with overweight and obesity will be randomly assigned to a beta-glucan or a cellulose (placebo) group (1:1 basis).
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60, women only. Healthy volunteers may be eligible.
You may be able to join if
- Healthy females living with overweight or obese (BMI of 25 - 39.9 kg/m2).
- Age between 18 to 60 years.
- Stable body weight for at least 3 months preceding the study.
You likely can't join if
- Smokers
- Irregular menstrual cycle
- Exercising more than 75min a week
- Pregnant or lactating
- Food allergies
- Vegan or vegetarian or follow any diet other than the typical Western diet.
See the full eligibility criteria
- Healthy females living with overweight or obese (BMI of 25 - 39.9 kg/m2).
- Age between 18 to 60 years.
- Stable body weight for at least 3 months preceding the study.
- Smokers
- Irregular menstrual cycle
- Exercising more than 75min a week
- Pregnant or lactating
- Food allergies
- Vegan or vegetarian or follow any diet other than the typical Western diet.
- Taking dietary supplement at the time of the study.
The study team makes the final eligibility decision.
Where it's taking place
- Glasgow, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glasgow, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.